NCT04298242View on ClinicalTrials.gov

Magnetic Resonance Guided High Intensity Focused Ultrasound in Advanced Pancreatic Adenocarcinoma Treatment

NACompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

November 22, 2020

Primary Completion Date

June 15, 2021

Study Completion Date

June 15, 2021

Conditions
Pancreatic Adenocarcinoma
Interventions
DEVICE

ExAblate 2100

A non-invasive thermal ablation device fully integrated with an MR imaging system

Trial Locations (1)

94304

Stanford Cancer Center, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT04298242 - Magnetic Resonance Guided High Intensity Focused Ultrasound in Advanced Pancreatic Adenocarcinoma Treatment | Biotech Hunter | Biotech Hunter